New human data hints at psychedelics' potential to combat inflammation

0:00-3:04

Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.

Publisher

All Things Considered

Published

October 21, 2026

Duration

3 min

Format

Podcast

Category

News · Daily News

Source

RSS feed

AT

All Things Considered

@allthingsconsidered

#humandatahints #psychedelicspotential #combatinflammation

The Nile